- ISIN
- US86889P1093
- CUSIP
- 86889P109
- Sector
- Healthcare
- Industry
- Biotechnology
- IPO Date
- Jan 11, 2021
Highlights
- Market Cap
- $166.07M
- Enterprise Value
- $67.87M
- EPS (TTM)
- -$23.90
- Total Revenue (TTM)
- $7.49M
- Gross Profit (TTM)
- $2.45M
- EBITDA (TTM)
- -$103.56M
- Year Range
- $9.03 - $35.00
- Target Price
- $40.00
- ROA (TTM)
- -178.16%
- ROE (TTM)
- 77.32%
- Avg. Volume (1M)
- 235K
- Avg. Volume Value (1M)
- $5.03M
Share Price Chart
Loading charts...
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Performance
SRZN Performance Chart
Surrozen, Inc. (SRZN) is down 1.7% since the beginning of the year. At $22 per share, SRZN is trading 36.5% below its 52-week high of $35. Investors who bought $1,000 worth of SRZN shares 5 years ago would now be looking at an investment worth $149.
Loading charts...
Compare this symbol against anything
Returns By Period
Surrozen, Inc. (SRZN) has returned -1.73% so far this year and 101.91% over the past 12 months.
Surrozen, Inc.
- 1D
- 6.63%
- 1M
- -10.87%
- 6M
- 3.09%
- YTD
- -1.73%
- 1Y
- 101.91%
- 3Y*
- 20.81%
- 5Y*
- -31.71%
- 10Y*
- —
- ALL TIME*
- -29.12%
Benchmark (S&P 500 Index)
- 1D
- 0.70%
- 1M
- 0.09%
- 6M
- 7.94%
- YTD
- 9.41%
- 1Y
- 20.07%
- 3Y*
- 17.84%
- 5Y*
- 11.25%
- 10Y*
- 13.26%
- ALL TIME*
- 8.09%
SRZN Monthly Returns History
Based on dividend-adjusted daily data since Jan 11, 2021, SRZN's average daily return is +0.04%, while the average monthly return is +0.46%. At this rate, an investment would double in approximately 12.6 years.
Historically, 52% of months were positive and 48% were negative. The best month was Feb 2024 with a return of +64.6%, while the worst month was Nov 2022 at -73.8%. The longest winning streak lasted 7 consecutive months, and the longest losing streak was 3 months.
On a daily basis, SRZN closed higher 47% of trading days. The best single day was Feb 9, 2023 with a return of +46.8%, while the worst single day was Apr 1, 2024 at -35.7%.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | -4.67% | 29.03% | 4.78% | 14.66% | -21.53% | -0.99% | -14.41% | -1.73% | |||||
| 2025 | -19.16% | -1.16% | 1.70% | -5.57% | -22.89% | 5.30% | 11.86% | 21.85% | 5.74% | 8.65% | 18.43% | 36.31% | 57.49% |
| 2024 | -15.96% | 64.56% | 20.85% | -31.51% | 4.18% | -2.32% | -26.39% | 31.99% | 12.62% | 12.19% | -9.23% | 17.62% | 52.66% |
| 2023 | 21.46% | 39.78% | -39.07% | 2.16% | 0.81% | -11.29% | 40.36% | -28.91% | -10.71% | -22.04% | 25.65% | 30.56% | 7.69% |
| 2022 | -62.89% | 26.36% | -0.33% | -14.62% | -3.50% | 20.97% | -15.00% | 0.78% | -21.40% | 13.50% | -73.83% | -3.02% | -90.96% |
| 2021 | 6.60% | -4.41% | -5.59% | 2.39% | 0.20% | 0.64% | 0.37% | -21.97% | -9.00% | -1.13% | 29.57% | -29.00% | -35.60% |
Benchmark Metrics
Surrozen, Inc. has an annualized alpha of 0.36%, beta of 0.67, and R2 of 0.01 versus S&P 500 Index. Calculated based on daily prices since January 11, 2021.
- This stock participated in 93.96% of S&P 500 Index downside but only -46.45% of its upside - more exposed to losses than it benefited from rallies.
- Beta of 0.67 may look defensive, but with R2 of 0.01 this stock is largely uncorrelated with S&P 500 Index - low beta reflects independence, not downside protection. See the Volatility section for a true picture of this stock's risk.
- R2 of 0.01 means this stock moves largely independently of S&P 500 Index - capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.
- Alpha
- 0.36%
- Beta
- 0.67
- R²
- 0.01
- Upside Capture
- -46.45%
- Downside Capture
- 93.96%
Return for Risk
Risk / Return Rank
SRZN ranks 85 for risk / return — above 85% of stocks peers on PortfoliosLab. Its historical combined result is among the stronger results in the peer group.
Risk / Return Metrics
The table below present risk-adjusted performance metrics for Surrozen, Inc. (SRZN) and compare them to S&P 500 Index.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| SRZN | Benchmark | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +0.22 | ||
| Sortino ratioReturn per unit of downside risk | +0.32 | ||
| Omega ratioGain probability vs. loss probability | 1.28 | 1.25 | +0.03 |
| Calmar ratioReturn relative to maximum drawdown | 2.81 | 2.00 | +0.80 |
| Martin ratioReturn relative to average drawdown | 7.44 | 8.49 | -1.05 |
Dividends
Dividend History
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.
Loading charts...
Worst Drawdowns
The table below displays the maximum drawdowns of the Surrozen, Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the Surrozen, Inc. was 97.25%, occurring on Nov 9, 2023. The portfolio has not yet recovered.
The current Surrozen, Inc. drawdown is 87.69%.
Drawdown | Fall | Recovery | Underwater | Related event |
|---|---|---|---|---|
-97.25%Nov 2023 | 2y 1mo | — | 4y 10moSep 2021 - now | — |
-34.52%Sep 2021 | 7mo 3d | 13d | 7mo 16dFeb 2021 - Sep 2021 | — |
-1.83%Jan 2021 | 3d | 1d | 4dJan 2021 - Jan 2021 | — |
-0.49%Jan 2021 | 1d | 5d | 5dJan 2021 - Jan 2021 | — |
-0.10%Jan 2021 | 1d | 1d | 1dJan 2021 - Jan 2021 | — |
Drawdown Indicators
| SRZN | Benchmark | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -97.25% | -56.78% | -40.47% |
Max Drawdown (1Y)Largest decline over 1 year | -43.74% | -9.10% | -34.64% |
Max Drawdown (3Y)Largest decline over 3 years | -62.70% | -18.90% | -43.80% |
Max Drawdown (5Y)Largest decline over 5 years | -97.25% | -25.43% | -71.82% |
Max Drawdown (10Y)Largest decline over 10 years | — | -33.92% | — |
Current DrawdownCurrent decline from peak | -87.69% | -1.58% | -86.11% |
Average DrawdownAverage peak-to-trough decline | -76.75% | -10.70% | -66.05% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 16.47% | 2.14% | +14.33% |
Volatility
Volatility Chart
The chart below shows the rolling one-month volatility.
Loading charts...
Financials
Financial Performance
The chart below illustrates the trends in the financial health of Surrozen, Inc. over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.
Valuation
The Valuation section provides an overview of how Surrozen, Inc. is priced in the market compared to other companies in the Biotechnology industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.
PS Ratio
This chart shows the Price-to-Sales (P/S) ratio for SRZN relative to other companies in the Biotechnology industry. Currently, SRZN has a P/S ratio of 26.7. This P/S ratio falls within the average range for the industry, suggesting the stock is fairly valued based on its revenue.
Income Statement
| TTM | |
|---|---|
Revenue | |
Total Revenue | — |
Cost Of Revenue | — |
Gross Profit | — |
Operating Expenses | |
Selling, General & Admin Expenses | — |
R&D Expenses | — |
Depreciation And Amortization | — |
Total Operating Expenses | — |
Income | |
Income Before Tax | — |
Operating Income | — |
EBITDA | — |
EBIT | — |
Earnings From Continuing Operations | — |
Net Income | — |
Income Tax Expense | — |
Other Non-Operating Income (Expenses) | — |
Extraordinary Items | — |
Discontinued Operations | — |
Effect Of Accounting Charges | — |
Non Recurring | — |
Minority Interest | — |
Other Items | — |
Interest Income | — |
Interest Expense | — |
Net Interest Income | — |
Build a portfolio with SRZN
Add Surrozen, Inc. to a portfolio and analyze allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Analyzer with SRZN